137 related articles for article (PubMed ID: 7559428)
1. Interleukin 4-inducible phosphorylation of HMG-I(Y) is inhibited by rapamycin.
Wang DZ; Ray P; Boothby M
J Biol Chem; 1995 Sep; 270(39):22924-32. PubMed ID: 7559428
[TBL] [Abstract][Full Text] [Related]
2. Independent pathways for de-repression of the mouse Ig heavy chain germ-line epsilon promoter: an IL-4 NAF/NF-IL-4 site as a context-dependent negative element.
Wang DZ; Cherrington A; Famakin-Mosuro B; Boothby M
Int Immunol; 1996 Jul; 8(7):977-89. PubMed ID: 8757943
[TBL] [Abstract][Full Text] [Related]
3. The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases.
Dennis PB; Pullen N; Kozma SC; Thomas G
Mol Cell Biol; 1996 Nov; 16(11):6242-51. PubMed ID: 8887654
[TBL] [Abstract][Full Text] [Related]
4. HMG I(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells.
Klein-Hessling S; Schneider G; Heinfling A; Chuvpilo S; Serfling E
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15311-6. PubMed ID: 8986808
[TBL] [Abstract][Full Text] [Related]
5. The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germ-line epsilon RNA promoter.
Kim J; Reeves R; Rothman P; Boothby M
Eur J Immunol; 1995 Mar; 25(3):798-808. PubMed ID: 7705411
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding.
Arnold SF; Obourn JD; Jaffe H; Notides AC
J Steroid Biochem Mol Biol; 1995 Nov; 55(2):163-72. PubMed ID: 7495695
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins.
John S; Reeves RB; Lin JX; Child R; Leiden JM; Thompson CB; Leonard WJ
Mol Cell Biol; 1995 Mar; 15(3):1786-96. PubMed ID: 7862168
[TBL] [Abstract][Full Text] [Related]
8. HMG-I(Y) phosphorylation status as a nuclear target regulated through insulin receptor substrate-1 and the I4R motif of the interleukin-4 receptor.
Wang D; Zamorano J; Keegan AD; Boothby M
J Biol Chem; 1997 Oct; 272(40):25083-90. PubMed ID: 9312117
[TBL] [Abstract][Full Text] [Related]
9. Anisomycin and rapamycin define an area upstream of p70/85S6k containing a bifurcation to histone H3-HMG-like protein phosphorylation and c-fos-c-jun induction.
Kardalinou E; Zhelev N; Hazzalin CA; Mahadevan LC
Mol Cell Biol; 1994 Feb; 14(2):1066-74. PubMed ID: 8289787
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y).
Chin MT; Pellacani A; Wang H; Lin SS; Jain MK; Perrella MA; Lee ME
J Biol Chem; 1998 Apr; 273(16):9755-60. PubMed ID: 9545312
[TBL] [Abstract][Full Text] [Related]
11. Replacement of conserved threonines by alanine residues in high mobility group protein HMG-I(Y): effect on DNA binding affinity.
Siino JS; Nissen MS; Reeves R
Biochem Biophys Res Commun; 1995 Feb; 207(2):497-507. PubMed ID: 7532403
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin-sensitive phosphorylation of ribosomal protein S17 by p70 S6 kinase.
Patel HR; Terada N; Gelfand EW
Biochem Biophys Res Commun; 1996 Oct; 227(2):507-12. PubMed ID: 8878544
[TBL] [Abstract][Full Text] [Related]
13. The HMG-I(Y) A.T-hook peptide motif confers DNA-binding specificity to a structured chimeric protein.
Banks GC; Mohr B; Reeves R
J Biol Chem; 1999 Jun; 274(23):16536-44. PubMed ID: 10347218
[TBL] [Abstract][Full Text] [Related]
14. Cdc2 and mitogen-activated protein kinases modulate DNA binding properties of the putative transcriptional regulator Chironomus high mobility group protein I.
Schwanbeck R; Wiśniewski JR
J Biol Chem; 1997 Oct; 272(43):27476-83. PubMed ID: 9341202
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of the sequence-specific HMG box of the lymphocyte transcriptional activator Sox-4.
van Houte LP; Chuprina VP; van der Wetering M; Boelens R; Kaptein R; Clevers H
J Biol Chem; 1995 Dec; 270(51):30516-24. PubMed ID: 8530483
[TBL] [Abstract][Full Text] [Related]
16. Constitutive phosphorylation of the acidic tails of the high mobility group 1 proteins by casein kinase II alters their conformation, stability, and DNA binding specificity.
Wiśniewski JR; Szewczuk Z; Petry I; Schwanbeck R; Renner U
J Biol Chem; 1999 Jul; 274(29):20116-22. PubMed ID: 10400623
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of the DNA-binding domain of nonhistone high-mobility group I protein by cdc2 kinase: reduction of binding affinity.
Reeves R; Langan TA; Nissen MS
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1671-5. PubMed ID: 2000376
[TBL] [Abstract][Full Text] [Related]
18. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter.
Chuvpilo S; Schomberg C; Gerwig R; Heinfling A; Reeves R; Grummt F; Serfling E
Nucleic Acids Res; 1993 Dec; 21(24):5694-704. PubMed ID: 8284217
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction between the DNA binding subunit trimerization domain of NF-Y and the high mobility group protein HMG-I(Y).
Currie RA
J Biol Chem; 1997 Dec; 272(49):30880-8. PubMed ID: 9388234
[TBL] [Abstract][Full Text] [Related]
20. Two discrete regions of interleukin-2 (IL2) receptor beta independently mediate IL2 activation of a PD98059/rapamycin/wortmannin-insensitive Stat5a/b serine kinase.
Kirken RA; Malabarba MG; Xu J; DaSilva L; Erwin RA; Liu X; Hennighausen L; Rui H; Farrar WL
J Biol Chem; 1997 Jun; 272(24):15459-65. PubMed ID: 9182578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
